Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00480155 · ClinicalTrials.gov registry record · Phase 2

A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults

A Phase 2 study of Healthy, sponsored by MedImmune.

Completed
Registry status
Phase 2
Development phase
300
Enrollment target
3
Study locations

NCT00480155 is a Phase 2 study of Healthy that has completed, run by MedImmune. The registered enrollment target is 300 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (54% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00480155, a Phase 2 study of Healthy, has completed, sponsored by MedImmune.

COMPLETED
Registry status
Phase 2
Development phase
300 participants
Enrollment target
3
Study locations

Study Summary

To assess the safety of a vaccine in healthy adults prior to the release of the vaccine (FluMist®) containing it.

Conditions Studied

Healthy

Interventions

  • OTHER Placebo
  • BIOLOGICAL Frozen FluMist®

Study Locations (3)

Florida

  • Covance Daytona Beach - Daytona Beach

Oregon

  • Covance Portland - Portland

Texas

  • Covance Austin CRU - Austin

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2007-05
Est. Completion 2007-12
Phase Phase 2

Sponsor

MedImmune

210 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00480155

The ClinicalTrials.gov registry entry for NCT00480155 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (54% lower). The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00480155 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Oregon, Texas.

Frequently Asked Questions

What is clinical trial NCT00480155 about?

NCT00480155 is a clinical study titled "A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults". To assess the safety of a vaccine in healthy adults prior to the release of the vaccine (FluMist®) containing it.

What is the current status of trial NCT00480155?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2007-05. Estimated completion is 2007-12.

What conditions does trial NCT00480155 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00480155?

The interventions under investigation include: Placebo (OTHER), Frozen FluMist® (BIOLOGICAL).

Who is sponsoring clinical trial NCT00480155?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00480155 being conducted?

This trial has 3 study locations across Florida, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.